-transparent.png){kind=logo}
Between March 1977 and December 1985, 59 patients were treated with intraperitoneal chromic phosphate at The University of Alabama Birmingham Hospitals and its affiliates. Twenty-seven patients received primary adjuvant therapy. Thirty-two patients were treated "secondarily" after tumor recurrence or after a "positive" second-look laparotomy. Associated morbidity was noted to be 12% with reoperation required in 7%. Early stage and grade tumors demonstrate a good prognosis. Little, if any, benefit was demonstrated in "secondary" therapy of advanced stage and grade tumors.
Related Publications
M E Potter, and
E E Partridge, and
H M Shingleton, and
S J Soong, and
R Y Kim, and
K D Hatch, and
J M Austin
January 1984,
Journal of the Medical Association of Georgia,
M E Potter, and
E E Partridge, and
H M Shingleton, and
S J Soong, and
R Y Kim, and
K D Hatch, and
J M Austin
March 1988,
Cancer,
M E Potter, and
E E Partridge, and
H M Shingleton, and
S J Soong, and
R Y Kim, and
K D Hatch, and
J M Austin
December 1987,
Southern medical journal,
M E Potter, and
E E Partridge, and
H M Shingleton, and
S J Soong, and
R Y Kim, and
K D Hatch, and
J M Austin
December 1982,
American journal of obstetrics and gynecology,
M E Potter, and
E E Partridge, and
H M Shingleton, and
S J Soong, and
R Y Kim, and
K D Hatch, and
J M Austin
January 1994,
Clinical nuclear medicine,
M E Potter, and
E E Partridge, and
H M Shingleton, and
S J Soong, and
R Y Kim, and
K D Hatch, and
J M Austin
December 1983,
American journal of obstetrics and gynecology,
M E Potter, and
E E Partridge, and
H M Shingleton, and
S J Soong, and
R Y Kim, and
K D Hatch, and
J M Austin
April 2007,
ONS connect,
M E Potter, and
E E Partridge, and
H M Shingleton, and
S J Soong, and
R Y Kim, and
K D Hatch, and
J M Austin
September 1991,
Cancer,
M E Potter, and
E E Partridge, and
H M Shingleton, and
S J Soong, and
R Y Kim, and
K D Hatch, and
J M Austin
April 1996,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M E Potter, and
E E Partridge, and
H M Shingleton, and
S J Soong, and
R Y Kim, and
K D Hatch, and
J M Austin
January 1990,
Gynecologic oncology,
